Literature DB >> 18702617

Long-term consequences of intracranial haemorrhage in children with haemophilia.

M Bladen1, K Khair, R Liesner, E Main.   

Abstract

Intracranial haemorrhages (ICH) in children with haemophilia are rare, and the outcome is variable, ranging from no apparent impairment to death. The aim of this investigation was to identify if children with haemophilia and ICH, have any long-term problems with motor function, visual motor integration or strengths and difficulties compared with a control group. A review of the Haemophilia Database at Great Ormond Street Hospital for Children NHS Trust was undertaken to identify boys with haemophilia and a history of ICH, as well as a control group of peers with no such history. Boys were born between January 1994 and December 2002. All boys were assessed using the movement Assessment Battery for Children, the Developmental Test of Visual Motor Integration and The Strengths and Difficulties Questionnaire as standardized assessments of motor competence, visual motor integration and behavioural difficulties. Six boys with haemophilia and ICH and 11 controls (mean age: 7 years; range: 4-12 years) were assessed. Children with ICH were significantly more likely to have problems with motor function and visual motor integration (Fisher's exact: P < 0.05). In addition, they had a tendency towards more problems with strengths and difficulties than their peer group (Fisher's exact: P = 0.06). Five of the six boys who had sustained an ICH were in mainstream schools; four requiring assistance with their education. The results of this small study suggest that ICH may signify long-term consequences for boys with haemophilia. The multidisciplinary team need to be aware of the rare but potentially important impact on motor function, visual motor integration and behaviour, which may inhibit the child from functioning optimally. An agreed comprehensive battery of assessments in collaboration with schools and healthcare workers is required to identify impairments to enable prompt interventions to be co-ordinated.

Entities:  

Mesh:

Year:  2008        PMID: 18702617     DOI: 10.1111/j.1365-2516.2008.01815.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

Review 1.  Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years.

Authors:  Ezio Zanon; Samantha Pasca
Journal:  Blood Transfus       Date:  2018-02-04       Impact factor: 3.443

2.  Intracranial hemorrhage in children with congenital factor deficiencies.

Authors:  Turkan Patiroglu; Mehmet Akif Ozdemir; Ekrem Unal; Yasemin Altuner Torun; Abdulhakim Coskun; Ahmet Menku; Fatma Turkan Mutlu; Musa Karakukcu
Journal:  Childs Nerv Syst       Date:  2011-07-12       Impact factor: 1.475

3.  Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: a case report and review.

Authors:  Tammuella Chrisentery Singleton; Matthew Keane
Journal:  Ochsner J       Date:  2012

4.  Urgent craniectomy for subdural hematoma in the 8-month-old infant with unrecognized hemophilia B.

Authors:  Jong Bun Kim; Hyun-Ju Jung; Kyong Shil Im; Sang Woo Han; Sang-Hun Lee
Journal:  Korean J Anesthesiol       Date:  2013-01-21

5.  Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.

Authors:  Elena Santagostino; Maria Messina; Annarita Tagliaferri; Alfonso Iorio; Massimo Morfini
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

6.  Visuoperceptual sequelae in children with hemophilia and intracranial hemorrhage.

Authors:  Guadalupe Morales; Esmeralda Matute; Erin T O'Callaghan; Joan Murray; Alberto Tlacuilo-Parra
Journal:  Transl Pediatr       Date:  2015-01

7.  The Utilization of Rehabilitation in Patients with Hemophilia A in Taiwan: A Nationwide Population-Based Study.

Authors:  Chien-Min Chen; Yao-Hsu Yang; Chia-Hao Chang; Chih-Cheng Chen; Pau-Chung Chen
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.